Company / Working Capital
Merck & Co. Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$15.2B
FY2025
5-year range
$6.4B / $15.2B
FY2021-FY2025
Trend
+46.6%
vs FY2024
Sector context
#2 of 213
Health Care
What the data says
Among 213 Health Care companies, Merck & Co. is in the top 1% for working capital. Working Capital has fluctuated over the past 10 years, ranging from $437M in FY2020 to $15.2B in FY2025.
Based on SEC 10-K filings.
$15.2B in FY2025 with a 5-year CAGR of +103.3%. Ranks 2nd among 213 companies in Health Care.
Improved from $6.5B to $15.2B over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +9.8%
- 5-Year CAGR
- +103.3%
- 10-Year CAGR
- -
Sector benchmark
Top 1% in Health CareTop 1% of 213This company $15.2B Sector average $934.6M
▼
+1525.2% above sector average
Key checks
Key Insights
- 5-year CAGR of +103.3%, indicating consistent growth.
- In FY2025, working capital increased 46.6% year-over-year.
- Ranks #2 out of 213 companies in the Health Care sector.
- Lowest working capital in the period was in FY2020.
Company context
Key Data Points
- Strong profit margin: 29.6%
- Strong return on equity: 36.7%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $15.2B | +46.6% |
| FY2024 | $10.4B | +60.1% |
| FY2023 | $6.5B | -43.6% |
| FY2022 | $11.5B | +79.6% |
| FY2021 | $6.4B | +1363.2% |
| FY2020 | $437.0M | -91.7% |
| FY2019 | $5.3B | +43.4% |
| FY2018 | $3.7B | -40.4% |
| FY2017 | $6.2B | -54.1% |
| FY2016 | $13.4B | +27.1% |
As of FY2025 · SEC 10-K · Updated Mar 9, 2026